1. Home
  2. PFGC vs VTRS Comparison

PFGC vs VTRS Comparison

Compare PFGC & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Performance Food Group Company

PFGC

Performance Food Group Company

HOLD

Current Price

$83.21

Market Cap

15.2B

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$13.07

Market Cap

17.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFGC
VTRS
Founded
1885
1961
Country
United States
United States
Employees
N/A
30000
Industry
Food Distributors
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.2B
17.2B
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
PFGC
VTRS
Price
$83.21
$13.07
Analyst Decision
Strong Buy
Buy
Analyst Count
9
4
Target Price
$116.44
$13.50
AVG Volume (30 Days)
1.3M
9.3M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
3.59%
EPS Growth
N/A
N/A
EPS
0.99
N/A
Revenue
$17,619,900,000.00
$14,299,900,000.00
Revenue This Year
$15.12
$4.45
Revenue Next Year
$6.62
$1.79
P/E Ratio
$85.79
N/A
Revenue Growth
5.12
N/A
52 Week Low
$68.40
$6.85
52 Week High
$109.05
$16.47

Technical Indicators

Market Signals
Indicator
PFGC
VTRS
Relative Strength Index (RSI) 37.31 34.13
Support Level $82.03 $12.92
Resistance Level $89.68 $13.49
Average True Range (ATR) 2.28 0.38
MACD -0.09 -0.09
Stochastic Oscillator 28.54 0.34

Price Performance

Historical Comparison
PFGC
VTRS

About PFGC Performance Food Group Company

Performance Food Group Co , markets and distributes national and company-branded food and food-related products. The company also specializes in distributing candy, snacks, beverages, cigarettes, other tobacco products, health and beauty care products and other items to vending distributors, box retailers, theaters, convenience stores, drug stores, grocery stores, travel providers, and hospitality providers. The company has three reportable segments: Foodservice, Vistar, and Convenience.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: